The Other Drug War: A History of Prescription Drug Abuse in America

 描述（由申请人提供）： 该项目的目的是研究、撰写和出版一本关于美国处方药滥用的学术史。 根据疾病控制中心的数据，处方药滥用已成为一种“流行病”，仅处方阿片类药物的死亡人数现在就超过了海洛因和可卡因的死亡人数。大多数观察家认为这是1990年代出现的一种新现象。这种被认为是新奇的东西在这场流行病最具文化说服力的叙述中扮演了关键角色：成瘾已经从非白色城市贫民的传统家园中脱离出来，通过药箱，在体面的白色黑人中横行，产生了（正如一则典型的新闻报道所说）“新一代成瘾者”。" 然而，这一流行病和对它的震惊反应都有很长的历史。正如对历史文献的粗略回顾所表明的那样，合法制造的镇静剂，兴奋剂和麻醉品（或为了方便起见，尽管时代错误，“处方药滥用”）的问题使用在一个多世纪以来经常使非法药物滥用相形见绌，药物当局和大众媒体在20世纪的大部分时间里一直在发现和重新发现这种流行病。 PI是一位经验丰富的制药、成瘾、医学和美国文化历史学家，他建议通过对食品和药物管理局、联邦麻醉品局、多个州的医疗和制药委员会、成瘾研究人员和制药公司的记录进行档案研究，以及对20世纪世纪出版记录的广泛研究，来记录这一漫长的佐贺，包括（但不限于）大众、医学和贸易媒体;国会听证会和调查;以及监管机构的报告。 通过将处方药滥用重新塑造为一种长期存在的现象，而不是一种最近的反常现象，拟议中的项目将提出有关美国人理解和管理毒品问题的方式的重要问题。它还提供了一个丰富的历史实验室，过去的经验和政策，为学者，卫生保健专业人员，政策制定者和执法机构提供信息，因为他们今天正在努力解决这些问题。

 DESCRIPTION (provided by applicant): The proposed project is to research, write, and publish a book-length scholarly history of prescription drug abuse in America. According to the Centers for Disease Control, prescription drug abuse has become an "epidemic," with deaths from prescription opioids alone now outpacing deaths from heroin and cocaine combined. Most observers identify this as a recent phenomenon originating in the 1990s. This presumed novelty plays a key role in the epidemic's most culturally compelling narrative: that addiction has escaped its traditional home among the nonwhite urban poor, and has, via the medicine cabinet, run amok in respectable white suburbia, producing (as one typical news report put it) a "new breed of addict." Both the epidemic and the shocked reactions to it, however, have a long history. As even a cursory review of historical literature demonstrates, problematic use of legally manufactured sedatives, stimulants, and narcotics (or for convenience despite the anachronism, "prescription drug abuse") has regularly dwarfed illicit drug abuse for over a century, and drug authorities and popular media have been discovering and re-discovering this epidemic for the better part of the 20th century. The PI, an experienced historian of pharmaceuticals, addiction, medicine, and American culture, proposes to document this long saga through archival research in the records of the Food and Drug Administration, the Federal Bureau of Narcotics, multiple state medical and pharmacy boards, addiction researchers, and pharmaceutical companies, as well as extensive research in the 20th century published record including (but not limited to) popular, medical, and trade media; Congressional hearings and investigations; and reports from regulatory agencies. By recasting prescription drug abuse as a longstanding phenomenon rather than a recent aberration, the proposed project will raise important questions about the way Americans understand and manage drug problems. It also provides a rich historical laboratory of past experiences and policies to inform scholars, health care professionals, policymakers, and law enforcement agencies as they grapple with those problems today.